Influence of Brain Insulin Sensitivity on Peripheral Insulin Sensitivity
- Conditions
- Insulin Sensitivity
- Interventions
- Drug: human insulin as nasal sprayDrug: Placebo
- Registration Number
- NCT01847456
- Lead Sponsor
- University Hospital Tuebingen
- Brief Summary
The researchers will investigate if brain insulin action influences peripheral insulin sensitivity in healthy humans.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 10
- BMI < 28 kg/m2
- normal HbA1c
- healthy volunteers
- Heparin induced thrombocytopenia (HIT)
- metal implants
- cardial diseases
- anemia
- patients taking any kind of drugs
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description insulin nasal spray human insulin as nasal spray 160 Units of human insulin as nasal spray Placebo nasal spray Placebo Nasalspray containing placebo solution
- Primary Outcome Measures
Name Time Method Insulin sensitivity as measured by clamp 45 minutes to 120 minutes post nasal spray We will measure insulin sensitivity by hyperinsulinemic euglycemic clamp before and after nasal spray application. We will compare the post-spray insulin sensitivity between the two condition (insulin nasal spray vs placebo nasal spray). Furthermore, we will compare insulin sensitivity before and after nasal insulin application.
- Secondary Outcome Measures
Name Time Method Autonomous nervous system activity 45 to 120 minutes post spray Activity of the autonomous nervous system will be estimated by heart rate variability in ECG. We will compare the post-spray autonomous nervous system activity between the two condition (insulin nasal spray vs placebo nasal spray). Furthermore, we will compare autonomous nervous system activity before and after nasal insulin application.
Trial Locations
- Locations (1)
University of Tuebingen, Internal medicine IV
🇩🇪Tuebingen, Germany